FedEx Named Overall Logistics & Supply Chain Management Supplier of the Year
Singapore, April 2, 2024 —FedEx Express (FedEx), a subsidiary of FedEx Corp. (NYSE: FDX) and one of the world’s largest express transportation companies, has been named ‘Overall Logistics & Supply Chain Management Supplier of the Year’ and also received the ‘Best Logistics & Supply Chain Management Supplier Award: Last Mile Implementation’ at the Asia-Pacific Biopharma Excellence Awards 2024 (ABEA 2024).
Organized by IMAPAC, ABEA 2024 seeks to give recognition to exceptional bioprocessing, logistics and supply chain management, as well as clinical trials experts, organizations, and technologies in the Asia region.
FedEx has built its healthcare capabilities over decades, including its dedicated healthcare team and cold chain network, to ship vaccines, biologics, and medical aid all around the world.
With a global network of more than 680 aircraft and 200,000 vehicles, and four Life Science Centers in the region including South Korea, Japan, Singapore and India, FedEx enables movement of healthcare shipments using temperature-controlled solutions and real-time monitoring using FedEx SenseAware to help protect shipment integrity.
Read More Business News
The company’s dedicated service, FedEx Clinical Care, provides an end-to-end shipping solution designed to transport precious biological samples at the exact speed and temperature required for safe, compliant clinical trials.
The author reflects on the pressures of the SPM exam in Malaysia, recognizing that true…
The FBM KLCI fell below 1,700 due to heightened Middle East tensions, despite earlier optimism…
Bursa Malaysia gains as easing geopolitical tensions lift Asian markets.
Malaysia’s PMI hits 50.7, signaling growth; rising costs, weaker demand and energy shocks weigh on…
In his new role, John will oversee MEASAT’s digital transformation, satellite and network engineering, IT…
Kawan Renergy reported a 25.9% QoQ and 5.6% YoY decline in core PATAMI, with earnings…
This website uses cookies.